S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-1.31%) $82.75
Gas
(6.34%) $2.05
Gold
(0.03%) $2 348.00
Silver
(-0.21%) $27.48
Platinum
(3.91%) $958.15
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.55%) $0.796
USD/RUB
(1.66%) $93.40

Echtzeitaktualisierungen für Sihuan Pharmaceutical [0460.HK]

Börse: HKSE Industrie: Drug Manufacturers
Zuletzt aktualisiert29 Apr 2024 @ 10:08

0.00% HKD 0.560

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 10:08):

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China...

Stats
Tagesvolumen 16.35M
Durchschnittsvolumen 7.60M
Marktkapitalisierung 5.20B
EPS HKD0 ( 2024-03-27 )
Last Dividend HKD0.0370 ( 2023-06-06 )
Next Dividend HKD0 ( N/A )
P/E -56.00
ATR14 HKD0.00100 (0.18%)

Volumen Korrelation

Lang: 0.02 (neutral)
Kurz: 0.00 (neutral)
Signal:(36.365) Neutral

Sihuan Pharmaceutical Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Sihuan Pharmaceutical Korrelation - Währung/Rohstoff

The country flag 0.57
( weak )
The country flag 0.67
( moderate )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.55
( weak negative )

Sihuan Pharmaceutical Finanzdaten

Annual 2023
Umsatz: HKD1.86B
Bruttogewinn: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2023
Umsatz: HKD1.86B
Bruttogewinn: HKD1.30B (69.64 %)
EPS: HKD-0.00580
FY 2022
Umsatz: HKD2.18B
Bruttogewinn: HKD1.49B (68.20 %)
EPS: HKD-0.210
FY 2021
Umsatz: HKD3.29B
Bruttogewinn: HKD2.45B (74.39 %)
EPS: HKD0.0440

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0360
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.0370
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Sihuan Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.27 - low (8.85%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.0390 2011-09-21
Last Dividend HKD0.0370 2023-06-06
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 23 --
Total Paid Out HKD0.764 --
Avg. Dividend % Per Year 0.00% --
Score 1.03 --
Div. Sustainability Score 3.27
Div.Growth Potential Score 0
Div. Directional Score 0.991 --
Next Divdend (Est)
(2024-10-25)
HKD0.0364 Estimate 3.62 %
Dividend Stability
0.29 Very Poor
Dividend Score
1.03
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3866.HK Ex Dividend Junior 2023-06-02 Annually 0 0.00%
1731.HK Ex Dividend Junior 2023-06-23 Sporadic 0 0.00%
0771.HK Ex Dividend Junior 2023-05-31 Sporadic 0 0.00%
2327.HK Ex Dividend Junior 2023-08-03 Sporadic 0 0.00%
1290.HK Ex Dividend Junior 2023-06-14 Sporadic 0 0.00%
0363.HK Ex Dividend Knight 2023-06-01 Annually 0 0.00%
6117.HK Ex Dividend Junior 2023-05-22 Sporadic 0 0.00%
1857.HK Ex Dividend Junior 2023-08-23 Semi-Annually 0 0.00%
0881.HK Ex Dividend Junior 2023-06-23 Annually 0 0.00%
0026.HK Ex Dividend Junior 2023-10-03 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02901.500-0.581-0.871[0 - 0.5]
returnOnAssetsTTM-0.004681.200-0.156-0.187[0 - 0.3]
returnOnEquityTTM-0.01221.500-1.247-1.870[0.1 - 1]
payoutRatioTTM-5.53-1.000-10.0010.00[0 - 1]
currentRatioTTM1.5110.8007.455.96[1 - 3]
quickRatioTTM1.1600.8007.886.30[0.8 - 2.5]
cashRatioTTM0.9201.5006.009.00[0.2 - 2]
debtRatioTTM0.106-1.5008.23-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM-0.005102.00-0.00255-0.00510[0 - 20]
debtEquityRatioTTM0.277-1.5008.89-10.00[0 - 2.5]
grossProfitMarginTTM0.6961.0001.7271.727[0.2 - 0.8]
operatingProfitMarginTTM-0.07361.000-3.47-3.47[0.1 - 0.6]
cashFlowToDebtRatioTTM0.02311.000-0.983-0.983[0.2 - 2]
assetTurnoverTTM0.1610.800-2.26-1.806[0.5 - 2]
Total Score3.27

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-85.441.000-8.730[1 - 100]
returnOnEquityTTM-0.01222.50-0.802-1.870[0.1 - 1.5]
freeCashFlowPerShareTTM-0.005102.00-0.00170-0.00510[0 - 30]
dividendYielPercentageTTM7.141.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM0.003182.0010.0010.00[0 - 30]
payoutRatioTTM-5.531.500-10.0010.00[0 - 1]
pegRatioTTM-0.9341.500-9.560[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01521.000-2.120[0.1 - 0.5]
Total Score-1.286

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.